{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:55:10Z","timestamp":1781740510083,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006523","name":"University of Dhaka","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102574","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T08:53:02Z","timestamp":1775206382000},"page":"102574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Whole exome sequencing identifies somatically mutated genes in bladder cancer: A pilot study from Bangladesh"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-3597","authenticated-orcid":false,"given":"Hasib Uddin","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Raiyan","family":"Hosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munshi Akid","family":"Mostofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Akmal","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Omar","family":"Faruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain Uddin","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKM Mahbub","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Ismail","family":"Hosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102574_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrep.2026.102574_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrep.2026.102574_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102574_bib4","series-title":"International Agency for Research on Cancer. GLOBOCAN","year":"2022"},{"key":"10.1016\/j.bbrep.2026.102574_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbrep.2026.102574_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrep.2026.102574_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.bbrep.2026.102574_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urolonc.2009.07.025","article-title":"Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways","volume":"29","author":"Wallerand","year":"2011","journal-title":"Urol. Oncol.: Seminars and Original Investigations"},{"key":"10.1016\/j.bbrep.2026.102574_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrep.2026.102574_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004128","article-title":"Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"6","author":"Safiri","year":"2021","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.bbrep.2026.102574_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ncb2956","article-title":"Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma","volume":"16","author":"Shin","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102574_bib12","series-title":"Bladder Cancer","first-page":"33","article-title":"Pathophysiology of bladder cancer","author":"Shin","year":"2018"},{"key":"10.1016\/j.bbrep.2026.102574_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23765","article-title":"The potential diagnosis role of TP53 mutation in advanced bladder cancer: a meta-analysis","volume":"35","author":"Liao","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bbrep.2026.102574_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.juro.2006.09.038","article-title":"Predictive value of cell cycle biomarkers in Nonmuscle invasive bladder transitional cell carcinoma","volume":"177","author":"Shariat","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.bbrep.2026.102574_bib15","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/1078-0432.CCR-14-1215","article-title":"Invasive bladder cancer: genomic insights and therapeutic promise","volume":"21","author":"Kim","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102574_bib16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4238\/2014.February.20.12","article-title":"Clinical significance of fibroblast growth factor receptor-3 mutations in bladder cancer: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bbrep.2026.102574_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrc1697","article-title":"Urothelial tumorigenesis: a tale of divergent pathways","volume":"5","author":"Wu","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2026.102574_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/bjc.2011.39","article-title":"Expression of NRG1 and its receptors in human bladder cancer","volume":"104","author":"Forster","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102574_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176034","article-title":"Activating telomerase tert promoter mutations and their application for the detection of bladder cancer","volume":"21","author":"Zvereva","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102574_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3329\/jbas.v49i1.81802","article-title":"Exploring the relationship between genetic polymorphisms and cancer in the Bangladeshi population","volume":"49","author":"Ahmed","year":"2025","journal-title":"J. Bangladesh Acad. Sci."},{"key":"10.1016\/j.bbrep.2026.102574_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2013.92","article-title":"ACMG clinical laboratory standards for next-generation sequencing","volume":"15","author":"Rehm","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrep.2026.102574_bib23","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","article-title":"A robust model for read count data in exome sequencing experiments and implications for copy number variant calling","volume":"28","author":"Plagnol","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrep.2026.102574_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12929-016-0269-9","article-title":"Zinc finger proteins in cancer progression","volume":"23","author":"Jen","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrep.2026.102574_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003129","article-title":"Involvement of members of the cadherin superfamily in cancer","volume":"1","author":"Berx","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrep.2026.102574_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13073-016-0370-4","article-title":"Technological considerations for genome-guided diagnosis and management of cancer","volume":"8","author":"Lennon","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.bbrep.2026.102574_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12920-020-00746-5","article-title":"Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples","volume":"13","author":"De Schaetzen Van Brienen","year":"2020","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.bbrep.2026.102574_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288371","article-title":"Evaluation of an optimized germline exomes pipeline using BWA-MEM2 and Dragen-GATK tools","volume":"18","author":"Alganmi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102574_bib29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cncy.21471","article-title":"Available resources and challenges for the clinical annotation of somatic variations","volume":"122","author":"Dumur","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.bbrep.2026.102574_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/onco.13839","article-title":"Comparison of genomic characterization in upper tract urothelial carcinoma and urothelial carcinoma of the bladder","volume":"26","author":"Yang","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrep.2026.102574_bib30","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.18632\/oncotarget.1555","article-title":"KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation","volume":"4","author":"Guo","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2026.102574_bib31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/curroncol29030117","article-title":"Urothelial bladder carcinomas with high tumor mutation burden have a better prognosis and targetable molecular defects beyond immunotherapies","volume":"29","author":"Voutsadakis","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbrep.2026.102574_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41065-020-00165-7","article-title":"Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes","volume":"158","author":"Chen","year":"2021","journal-title":"Hereditas"},{"key":"10.1016\/j.bbrep.2026.102574_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ajpath.2018.11.018","article-title":"Integrated fourier transform infrared imaging and proteomics for identification of a candidate histochemical biomarker in bladder cancer","volume":"189","author":"Witzke","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrep.2026.102574_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081748","article-title":"Prognostic impact of ahnak2 expression in patients treated with radical cystectomy","volume":"13","author":"Koguchi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrep.2026.102574_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020244","article-title":"The role of p53 mutations in early and late response to mitotic aberrations","volume":"15","author":"Hertel","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrep.2026.102574_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s40001-024-01828-1","article-title":"Inactivation of KDM6A promotes the progression of colorectal cancer by enhancing the glycolysis","volume":"29","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrep.2026.102574_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/jcm8060903","article-title":"Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication","volume":"8","author":"Hung","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrep.2026.102574_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3605","article-title":"PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data","volume":"16","author":"Zardavas","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102574_bib40","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.cub.2006.09.005","article-title":"The fat cadherin acts through the Hippo tumor-suppressor pathway to regulate tissue size","volume":"16","author":"Willecke","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrep.2026.102574_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10238-024-01365-5","article-title":"MUC16: clinical targets with great potential","volume":"24","author":"Zhang","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bbrep.2026.102574_bib42","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.2147\/OTT.S281517","article-title":"AHNAK2 promotes migration, invasion, and epithelial-mesenchymal transition in lung adenocarcinoma cells via the TGF-\u03b2\/Smad3 pathway","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrep.2026.102574_bib43","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrc3816","article-title":"Hypermutation in human cancer genomes: footprints and mechanisms","volume":"14","author":"Roberts","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.bbrep.2026.102574_bib48","first-page":"1","article-title":"AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2026.102574_bib44","first-page":"1","article-title":"Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fraction","volume":"9","author":"Sisoudiya","year":"2025","journal-title":"npj Precis. Oncol."},{"issue":"22","key":"10.1016\/j.bbrep.2026.102574_bib45","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1186\/s12885-022-09897-3","article-title":"Bias and inconsistency in the estimation of tumour mutation burden","volume":"22","author":"Makrooni","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrep.2026.102574_bib46","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/s41467-018-05936-5","article-title":"Extremely rare variants reveal patterns of germline mutation rate heterogeneity in humans","volume":"9","author":"Carlson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2026.102574_bib47","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/bioinformatics\/btac335","article-title":"Examining clustered somatic mutations with SigProfilerClusters","volume":"38","author":"Bergstrom","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrep.2026.102574_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115318","article-title":"Comprehensive evaluation of the PCDHB family in gastric cancer: prognostic significance, immune infiltration, and experimental validation of PCDHB5's oncogenic role","volume":"163","author":"Zhou","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrep.2026.102574_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300489120","article-title":"A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells","volume":"120","author":"Ginn","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2026.102574_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cels.2015.08.014","article-title":"Pan-Cancer analysis of mutation hotspots in protein domains","volume":"1","author":"Miller","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.bbrep.2026.102574_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70375","article-title":"G protein-coupled receptor signaling: implications and therapeutic development advances in cancers","volume":"6","author":"Khan","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.bbrep.2026.102574_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in Cancer-A review","volume":"21","author":"Kaszak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102574_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013821","article-title":"FGFR3, HRAS, KRAS, NRAS AND PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy","volume":"5","author":"Kompier","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102574_bib55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI78185","article-title":"NOTCH pathway inactivation promotes bladder cancer progression","volume":"125","author":"Maraver","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102574_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jcmm.13293","article-title":"Emerging role of Hippo signalling pathway in bladder cancer","volume":"22","author":"Xia","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrep.2026.102574_bib57","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/ng.3934","article-title":"A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer","volume":"49","author":"Polak","year":"2017","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.bbrep.2026.102574_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12915-022-01316-0","article-title":"APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types","volume":"20","author":"Jakobsdottir","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.bbrep.2026.102574_bib59","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-023-06234-x","article-title":"Y chromosome loss in cancer drives growth by evasion of adaptive immunity","volume":"619","author":"Abdel-Hafiz","year":"2023","journal-title":"Nature"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:41:50Z","timestamp":1781739710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"alternative-id":["S2405580826001342"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102574","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole exome sequencing identifies somatically mutated genes in bladder cancer: A pilot study from Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102574"}}